Kröger H, Grätz R, Dietrich A, Grahn H
Gen Pharmacol. 1987;18(1):37-9. doi: 10.1016/0306-3623(87)90167-4.
Oxypangam is a substance applied therapeutically against a number of diseases, such as chronic liver damages, angina pectoris, and psychosomatic disturbances. The mode of action of oxypangam has not yet conclusively been described. The only well-known properties of this substance are its intensive methylating and lipolytic effects. The present paper serves to elucidate the influence of oxypangam on the induction of the tyrosine aminotransferase, on the NAD content and on the activity of the ADPR transferase in the liver. Our studies showed that in normal animals, increasing doses of oxypangam support the induction of tyrosine aminotransferase. Up to a concentration of 100 mg/kg oxypangam enhances also the induction of tyrosine aminotransferase by tryptophan. In both cases, however, it does not work in adrenalectomized animals. Under the influence of oxypangam the NAD content of the liver remained unchanged, while the activity of the ADPR transferase was influenced only slightly.
氧化泛酰胺是一种用于治疗多种疾病的物质,如慢性肝损伤、心绞痛和身心障碍。氧化泛酰胺的作用方式尚未得到确切描述。这种物质唯一为人所知的特性是其强烈的甲基化和脂解作用。本文旨在阐明氧化泛酰胺对肝脏中酪氨酸转氨酶诱导、NAD含量以及ADPR转移酶活性的影响。我们的研究表明,在正常动物中,增加氧化泛酰胺的剂量可促进酪氨酸转氨酶的诱导。在浓度高达100mg/kg时,氧化泛酰胺还可增强色氨酸对酪氨酸转氨酶的诱导作用。然而,在这两种情况下,它对肾上腺切除的动物均无作用。在氧化泛酰胺的影响下,肝脏的NAD含量保持不变,而ADPR转移酶的活性仅受到轻微影响。